Tag Archives: antibiotics

Dentists urged to reduce prescriptions of pre-treatment antibiotics

Mary Otto

About Mary Otto

Mary Otto, a Washington, D.C.-based freelancer, is AHCJ's topic leader on oral health and the author of "Teeth: The Story of Beauty, Inequality, and the Struggle for Oral Health in America." She can be reached at mary@healthjournalism.org.

Clostridioides difficile

Across America, dentists write about 10% of all antibiotic prescriptions, data show, making them the top specialty prescribers of antibiotics in the U.S. one recent year.

But do the benefits of all these prescriptions outweigh their potential for harm? Amid concerns about antibiotic resistance – and the spread of Clostridioides difficile, a bacterium that causes antibiotic-associated colitis – researchers are saying “no.” Continue reading

How a journalist overcame challenges of covering antibiotic resistance

Bara Vaida

About Bara Vaida

Bara Vaida (@barav) is AHCJ's core topic leader on infectious diseases. An independent journalist, she has written extensively about health policy and infectious diseases. Her work has appeared in outlets that include the National Journal, Agence France-Presse, Bloomberg News, McClatchy News Service, MSNBC, NPR, Politico and The Washington Post.

Since the dawn of antibiotics, there has been antibiotic resistance. Until about 20 years ago, this threat remained muted because there were plenty of new antibiotics in the pipeline to replace those that had stopped working.

Today, there are fewer than 50 antimicrobials in the pipeline, according to Pew Charitable Trusts. Resistant bacteria, meanwhile, are slowly but surely spreading across the planet. If nothing changes, British think tank the Wellcome Trust, estimates that 10 million people will die annually from a resistant microbe by 2050. Continue reading

Scientists look for new antimicrobials and urge government incentives

Bara Vaida

About Bara Vaida

Bara Vaida (@barav) is AHCJ's core topic leader on infectious diseases. An independent journalist, she has written extensively about health policy and infectious diseases. Her work has appeared in outlets that include the National Journal, Agence France-Presse, Bloomberg News, McClatchy News Service, MSNBC, NPR, Politico and The Washington Post.

Photo: CDC/ Melissa Dankel

Researchers are looking to old drugs, plants and viruses in a race to find new ways to kill disease-causing microbes before they become resistant to all existing pharmaceuticals, but their work will flounder if the federal government can’t figure out how to incentive companies to turn their work into commercially viable drugs. Continue reading

Panel to look at challenges of fighting superbugs

Bara Vaida

About Bara Vaida

Bara Vaida (@barav) is AHCJ's core topic leader on infectious diseases. An independent journalist, she has written extensively about health policy and infectious diseases. Her work has appeared in outlets that include the National Journal, Agence France-Presse, Bloomberg News, McClatchy News Service, MSNBC, NPR, Politico and The Washington Post.

Since antibiotics were widely introduced in the mid 1940’s, scientists warned of microbes’ innate ability to evolve and develop resistance. People were cautioned to be judicious with antimicrobials, because overuse could breed “superbugs,” germs resistant to most or all antibiotics.

Indeed, microbes have developed resistance to virtually every new class of antibiotics introduced. Up until the 1980s, however, most pharmaceutical companies kept developing new antibiotics. When a drug developed resistance, there was a new one in the development pipeline that could take its place. Continue reading

Antibiotic resistance highlighted at World Conference of Science Journalists

Tara Haelle

About Tara Haelle

Tara Haelle (@TaraHaelle) is AHCJ's medical studies core topic leader, guiding journalists through the jargon-filled shorthand of science and research and enabling them to translate the evidence into accurate information.

U.S. Centers for Disease Control and Prevention

Alexander Fleming developed penicillin, the first antibiotic, in 1928. In less than a century, scientists have developed more than 130 other antibiotics — saving millions of lives, making surgery safer than ever, transforming medicine … and creating the huge new problem of antibiotic resistance that threatens to toss us back into the pre-antibiotic era.

Take gonorrhea for just one example: humans have gone from having no way to treat the disease in the 1920s to having effective antibiotics against it to now, when the “bacteria has developed resistance to nearly every drug used for treatment,” according to the CDC. Continue reading

New CDC antibiotic resistance map is a potential source for story ideas

Bara Vaida

About Bara Vaida

Bara Vaida (@barav) is AHCJ's core topic leader on infectious diseases. An independent journalist, she has written extensively about health policy and infectious diseases. Her work has appeared in outlets that include the National Journal, Agence France-Presse, Bloomberg News, McClatchy News Service, MSNBC, NPR, Politico and The Washington Post.

Staphylococcus aureus

Looking for a local angle to cover antibiotic resistance?

Reporters can find potential stories by looking at the Centers for Disease Control and Prevention’s newly released antibiotic resistance investment map which provides details on superbug cases in states and CDC efforts to contain their spread. Continue reading